Central and peripheral actions of anticholinergic drugs when administered with triflupromazine.
D000818:Animals; D001143:Arousal / Q000187:drug effects*; D001285:Atropine / Q000494:pharmacology; D001561:Benzilates / Q000494:pharmacology; D003517:Cyclopentanes / Q000494:pharmacology; D004357:Drug Synergism; D004569:Electroencephalography; D008333:Mandelic Acids / Q000494:pharmacology; D051379:Mice; D009184:Mydriatics / Q000494:pharmacology; D063065:Organophosphonates / Q000494:pharmacology; D010276:Parasympatholytics / Q000494:pharmacology*; D011760:Pyrrolidinones / Q000037:antagonists & inhibitors; D012472:Salivation / Q000187:drug effects; D012601:Scopolamine / Q000494:pharmacology; D014203:Tremorine / Q000494:pharmacology; D014273:Triflupromazine / Q000494:pharmacology*
D001561:Benzilates; D003517:Cyclopentanes; D008333:Mandelic Acids; D009184:Mydriatics; D063065:Organophosphonates; D010276:Parasympatholytics; D011760:Pyrrolidinones; D001285:Atropine; D012601:Scopolamine; D014273:Triflupromazine; D014203:Tremorine